Showing results (31-40 of 186) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|January 10, 2021
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriersNeda Stjepanovic, Jan Lubinski, Pal Moller, et al.BMJ (Clinical Research Ed.)|February 13, 2014
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisKelly Metcalfe, Shelley Gershman, Parviz Ghadirian, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriersJoanne Kotsopoulos, Beth Karlan, Jacek Gronwald, et al.JCO Oncology Practice|December 6, 2022
Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer TreatmentGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.Familial Cancer|May 8, 2004
Cancer variation associated with the position of the mutation in the BRCA2 geneJan Lubinski, Catherine M Phelan, Parviz Ghadirian, et al.JAMA Oncology|July 17, 2015
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.European Journal of Cancer (Oxford, England : 1990)|March 9, 2023
OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerMark E Robson, Seock-Ah Im, Elzbieta Senkus, et al.Fertility and Sterility|February 19, 2013
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutationAmy Finch, Adriana Valentini, Ellen Greenblatt, et al.Cell Stem Cell|February 8, 2011
Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fateTheresa A Proia, Patricia J Keller, Piyush B Gupta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.Pageof 19